Literature DB >> 17984618

The polymorphism in acetaldehyde dehydrogenase 2 gene, causing a substitution of Glu > Lys(504), is not associated with coronary atherosclerosis severity in Han Chinese.

Feng Xu1, Yu-Guo Chen, Yong-Jian Geng, He Zhang, Chun-Xiao Jiang, Yi Sun, Rui-Jian Li, Madi Bidya Sagar, Li Xue, Yun Zhang.   

Abstract

Alcohol consumption has an important effect on coronary atherosclerotic heart disease (CAD). Acetaldehyde dehydrogenase 2 (ALDH2) is a key enzyme in alcohol metabolism. A G-to-A missense mutation of ALDH2 gene, which causes a Glu > Lys(504) substitution, was recently shown to be associated with carotid atherosclerosis; however, its relationship with coronary atherosclerosis has not been well studied. We, therefore, investigated this relationship in Han Chinese. There are two ALDH2 alleles (1 and 2) and their combination: 1/1 (GG, typical homozygote), 1/2 (GA, heterozygote) and 2/2 (AA, atypical homozygote) in the population. Successive Han Chinese, including 89 with myocardial infarction (MI) and 142 with unstable angina, were recruited, and underwent coronary angiography and gene sequencing. Coronary atherosclerosis severity was expressed by the number of lesioned coronary arteries (>or=50% diameter stenosis) and Gensini score, calculated based on the luminal narrowing degree and its geographic importance, as assessed by angiography. Based on their ALDH2 genotypes, the 231 patients were divided into wild-type (1/1, n = 145) and mutation groups (1/2 and 2/2, n = 86). There were no significant differences in basic clinical data between the two groups; however, the mutation group had significantly higher rates of diabetes mellitus and MI, and lower prevalence of alcohol consumption than wild-type group. Yet, the two groups were not significantly different in coronary atherosclerosis severity. Multiple regression analysis has shown that the ALDH2 genotype 1/2 or 2/2 is an independent risk factor for MI, but is not associated with coronary atherosclerosis severity in Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984618     DOI: 10.1620/tjem.213.215

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  4 in total

1.  Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome.

Authors:  Feng Xu; Yu Guo Chen; Li Xue; Rui Jian Li; He Zhang; Yuan Bian; Cheng Zhang; Rui Juan Lv; Jin Bo Feng; Yun Zhang
Journal:  J Cell Mol Med       Date:  2011-09       Impact factor: 5.310

2.  Tacrolimus reduces atherosclerotic plaque formation in ApoE-/- mice by inhibiting NLRP3 inflammatory corpuscles.

Authors:  Xiao Li; Xingfu Shang; Lu Sun
Journal:  Exp Ther Med       Date:  2019-12-17       Impact factor: 2.447

3.  Isoflurane preconditioning confers cardioprotection by activation of ALDH2.

Authors:  Xiao-E Lang; Xiong Wang; Ke-Rang Zhang; Ji-Yuan Lv; Jian-Hua Jin; Qing-Shan Li
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

4.  Precision medicine approach: Empagliflozin for diabetic cardiomyopathy in mice with aldehyde dehydrogenase (ALDH) 2 * 2 mutation, a specific genetic mutation in millions of East Asians.

Authors:  Guodong Pan; Mandar Deshpande; Haiyan Pang; Suresh Selvaraj Palaniyandi
Journal:  Eur J Pharmacol       Date:  2018-09-19       Impact factor: 5.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.